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“I 
Chemical agents  which activate specific kinases 
were employed to disrupt the stress fiber and focal 
adhesion  organization of cells spread  on a substratum. 
The  phorbol ester 12-O-tetradecanoylphorbol-13-ace- 
tate, an  activator  of  protein ki ase C, promoted a rapid 
loss of stress fibers and focal  adhesions  from  African 
green  monkey  kidney (BSC-1) cells. This was paral- 
leled by  an increase  in  the level of  talin  phosphoryla- 
tion  suggesting  that this may play a role  in  the  removal 
of talin from focal adhesions. Similar morphological 
changes were produced in the rat embryo fibroblast 
line (REF 52) by dibutyryl-CAMP, which stimulates 
protein  kinase A.  In contrast, however, the  phosphor- 
ylation of talin was reduced in REF 52 cells when 
treated with dibutyryl CAMP. In untreated cells we 
found  that  the levels of  vinculin  phosphorylation were 
very  low relative to  the levels of talin phosphorylation 
and  did  not  change  following  drug  treatment  in e ther 
cell line. Although  limited  proteolytic cleavage of cy- 
toskeletal  proteins  represents a potential  mechanism 
for  focal  adhesion  disruption,  we  observed  no  proteol- 
ysis of talin or vinculin in response to either drug 
treatment. 
In tissue culture, spreading cells often form transmembrane 
linkages between the extracellular matrix and the F-actin 
cytoskeleton in regions of the cell where the plasma membrane 
comes in closest proximity to  the substratum. Using a variety 
of immunohistochemical and biochemical procedures several 
proteins have been localized to these specialized regions 
known as focal adhesions or focal contacts (Burridge et al., 
1988). Among these are the integrins (Buck and Horwitz, 
1987; Hynes, 1987; Ruoslahti and Pierschbacher, 1987), a 
family of glycoproteins, which span the plasma membrane 
and bind both extracellular matrix components, such as fibro- 
nectin and vitronectin (Honvitz et al., 1985; Akiyama et al., 
1986; Buck and Horwitz, 1987) as well as  talin (Horwitz et 
al., 1986), which is present in focal adhesions at  the intracel- 
lular face of the plasma membrane (Burridge and Connell, 
1983a,  1983b). Another cytoskeletal element, vinculin, inter- 
acts  both with talin (Burridge and Mangeat, 1984) and,  albeit 
weakly, with a-actinin  (Otto, 1983; Wilkins et al., 1983; Bur- 
ridge and Mangeat, 1984; Craig, 1985; Wachsstock et al., 
1987). In view of the additional affinity of a-actinin for F- 
actin (Maruyama and Ebashi, 1965; Burridge and Feramisco, 
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1981) a series of protein-protein  interactions  can be mapped 
out extending from the extracellular matrix through focal 
adhesions to  the F-actin  stress fibers within the cell. It seems 
likely, however, that  other proteins  are also involved in  this 
linkage (for review see Burridge et al., 1988). 
The importance of each of these  interactions  in the main- 
tenance of a stable focal adhesion remains unclear. The 
integrity of these adhesions can be disrupted by a variety of 
physiological and pharmacological factors. During the cell 
cycle, spread cells in culture round up  prior to division and 
subsequently respread forming new focal adhesions. Trans- 
formation by some viruses, such as Rous sarcoma virus, 
reveals a different focal adhesion phenotype (David-Pfeuty 
and Singer, 1980; Tarone et al., 1985). The oncogenes acti- 
vated during transformation often exhibit potent tyrosine 
kinase activity (Hunter  and Sefton, 1980; Gentry  and 
Rohrschneider, 1984; Tarone et al., 1985). Observations that 
vinculin (Sefton et al., 1981), talin (Pasquale et al., 1986; 
DeClue and  Martin, 1987), and  integrin (Hirst et al., 1986) 
become phosphorylated at tyrosine residues in  certain virally 
transformed cells led to  the suggestion that these  phosphor- 
ylation  events could be responsible for the less stable  nature 
of focal adhesions in  these cells compared to those expressing 
a more normal phenotype. However, the importance of these 
changes is in question since the use of mutant virus strains 
which did not  alter  the morphology of cells produced similar 
tyrosine phosphorylation of vinculin (Rohrschneider and Ro- 
sok, 1983; Iwashita et al., 1983; Antler et al., 1985; Rohrsch- 
neider and Reynolds, 1985; Kellie et al., 1986; Nigg et al., 
1986) and  talin (DeClue and  Martin, 1987). 
Evidence suggesting that phosphorylation may be an im- 
portant factor in the disruption of focal adhesions in “normal” 
cells has been obtained using chemical activators of specific 
kinases. In certain cell types the tumor-promoting phorbol 
ester 12-O-tetradecanoylphorbol-13-acetate (TPA)’ induces 
rapid loss of stress fibers and  a  concomitant  redistribution of 
vinculin (Schliwa et al., 1984; Kellie et al., 1985) and  a-actinin 
(Meigs and Wang, 1986) from focal adhesions probably via 
the activation of protein kinase C (Nishizuka, 1984). The 
talin  distribution under these conditions was not determined. 
Lamb et al. (1988) obtained similar disruption of stress fibers 
in REF 52 cells via the activation of the cyclic AMP  (CAMP)- 
dependent protein kinase (A kinase) either by the use of 
stable  synthetic analogues of CAMP or microinjection of the 
catalytic  subunit of A kinase. The effect on the distribution 
of focal adhesion proteins was not investigated. 
Cleavage of talin  or vinculin by specific proteases  represents 
’ The abbreviations used are: TPA, 12-O-tetradecanoylphorbol-13- 
acetate; DMEM, Dulbecco’s modified Eagle’s medium; TBS, Tris- 
buffered saline; Bt2cAMP, dibutyryl cyclic AMP; MIX, 3-isobutyl-l- 
methylxanthine; Me2S0, dimethyl sulfoxide; SDS, sodium dodecyl 
sulfate. 
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another potential mechanism for regulating focal adhesion 
organization. Talin is a preferred substrate in vitro for the 
calcium-dependent protease (CDP 11) (Calpain 11), being read- 
ily  cleaved to stable  fragments of 190 and 47 kDa in  the case 
of chicken smooth muscle talin (O'Halloran and Burridge, 
1986) or 200 and 47 kDa for platelet  talin (P235) (Collier and 
Wang, 1982; Fox et al., 1985; O'Halloran et al., 1985; Beckerle 
et al., 1986). The idea that limited proteolysis of cytoskeletal 
proteins, including talin, may be important  in regulating the 
organization of intracellular  structures like focal adhesions is 
supported by data concerning platelet  activation and aggre- 
gation by thrombin,  in which a calcium-dependent proteolysis 
of both filamin and talin accompanies major cytoskeletal 
reorganization (Fox et al., 1985). Additionally, immunohisto- 
chemical studies have revealed a colocalization of Calpain I1 
and  talin  to focal adhesions in  a variety of cell types (Beckerle 
et al., 1987) providing circumstantial evidence that  the cleav- 
age of talin could be a factor in  promoting focal adhesion and 
stress fiber disassembly. 
We have attempted to answer biochemically some of the 
questions raised in  the morphological studies described above. 
To this end, we have investigated the  state of phosphorylation 
of both  talin  and vinculin during focal adhesion disruption 
following specific kinase activation. Similarly, we have ex- 
plored the role of proteolytic cleavage of these two proteins 
during this cytoskeletal reorganization. 
MATERIALS AND METHODS 
Cell Culture-African green monkey kidney cells (BSC-1) and  rat 
embryo fibroblasts (REF-52) were grown in Dulbecco's modified 
Eagle's medium (DMEM, GIBCO) supplemented with 10%  fetal calf 
serum (GIBCO), 50 units/ml penicillin, and 50 pg/ml streptomycin 
and grown at 37 "C in 5% COZ. 
Fluorescence  Microscopy-Cells  for immunofluorescence were 
grown on glass coverslips for 24-48 h prior to use in medium contain- 
ing  10%  fetal calf serum. Cells were fixed in 3.7% formaldehyde (v/ 
v) in phosphate-buffered saline (pH 7.4) for 10 min. They were then 
washed in TBS (150 mM NaCl,O.l% NaN3, 50 mM Tris-HC1, pH 7.6) 
for 5 min, followed by permeabilization with 0.2% (v/v) Triton  X- 
100 in TBS for 5 min, then washed an additional  5 min in  fresh  TBS. 
Cells were incubated in  primary antibody (rabbit anti-talin or guinea 
pig anti-vinculin)  diluted  in TBS for 1 h at 37 "C. Excess antibody 
was removed by washing for 5 min in TBS. The cells were then 
incubated with the second antibody (fluorescein-conjugated goat anti- 
rabbit Ig or goat anti-guinea pig  Ig, Cappel Laboratories, Cochranville, 
PA) diluted 1:50 plus rhodamine-conjugated phalloidin (Molecular 
Probes, Inc., Eugene, OR) diluted 1:300 for 1 h a t  37 "C. The coverslips 
were washed for 5 min in  TBS, then rinsed briefly in deionized water, 
and mounted in Gelvatol (Monsanto). The cells were observed using 
a Zeiss IM-35 photomicroscope with a X 63 oil immersion objective 
and photographed with Tri-X film (Kodak). 
Metabolic  Labeling of Cells-Cells were  grown for 24-48 h before 
radiolabeling. For phosphorylation experiments cells were  grown with 
["P]orthophosphate (Du Pont-New  England Nuclear, carrier-free  in 
water) at 0.75 mCi/ml for 2  or 4 at  37 "C in  phosphate-free DMEM 
supplemented with 10% fetal calf serum that had been dialyzed 
against phosphate-free saline (0.15 M NaCl). [35S]Methionine-labeled 
cells were  grown in DMEM containing  10% of the usual concentration 
of methionine and supplemented with 10% dialyzed fetal calf serum 
and glutamine containing 50 pCi/ml [35S]methionine (Amersham 
Corp.) for 18 h at  37 "C. 
Drug Treatment-Cells grown to approximately 50-75% con- 
fluency were treated with either TPA or  a mixture of dibutyryl cyclic 
AMP (BhcAMP) and 3-isobutyl-1-methylxanthine (MIX), all ob- 
tained from Sigma. TPA, BtzcAMP, and MIX were diluted into 
DMEM before use from 1 mg/ml stocks  in Me2S0 stored at  -20 "C. 
TPA was used at a  final  concentration of 100 ng/ml; Bt2cAMP and 
MIX were used at 2 mM. Control cells were treated with DMEM 
containing the same  concentration of M e 8 0  without drugs. 
Immunoprecipitation, Polyacrylamide Gel Electrophoresis, and Au- 
toradiography-Radiolabeled cells that had been grown in 60-mm 
dishes were washed three times with Hank's buffered saline solution 
following drug  or MezSO (control) treatments  and solubilized in 60 
pl of gel sample buffer (Laemmli, 1970) containing  6-mercaptoethanol 
plus 60  pl of deionized water. Cells were scraped from the dish using 
a Teflon spatula and  then drawn repeatedly through  a 26-gauge needle 
to shear DNA. The sample was then transferred to a 1.5-ml Eppendorf 
tube and diluted to 1 ml with TBS containing 1% Triton X-100 and 
1% deoxycholate which reduced the SDS  concentration to approxi- 
mately 0.1%. This cell extract was incubated with 150 pl of a 10% w/ 
v solution of Staph A cells (Pansorbin, Calbiochem) for 1 h at 25 "C 
to remove cellular proteins binding to protein A. The  Staph A was 
sedimented and  an excess of either  rabbit  anti-talin or guinea pig 
anti-vinculin was added to the  supernatant  and  then incubated for 1 
h at  25 "C.  100  pl of a 10%  w/v suspension of protein A-Sepharose 
(Pharmacia LKB Biotechnology Inc.) was added to the mixture, 
which was incubated for an additional 1 h at 25  'C. The complexes 
containing bound antigen were pelleted and washed three times with 
TBS containing 1% Triton-100,1% deoxycholate, and 0.1% SDS. 15 
p1 of  gel sample buffer was added to  the final pellet, which  was  boiled 
for 5 min to release bound antigen. 
Samples were electrophoresed on 10% SDS-polyacrylamide gels 
according to  the methods of Laemmli (1970) except the bisacrylamide 
concentration was 0.13%. 32P gels  were fixed for 15 min in 7% acetic 
acid/lO% methanol, and 35S gels were fixed and  then  treated with 
Amplify (Amersham Corp.) for 30 min before they were dried and 
exposed to Kodak XAR-5 film with an intensifying screen at  -70  "C. 
Densitometry was performed using a Hoefer GS 300 scanning  densi- 
tometer. 
Determination of the Extent of Talin Phosphorylation-To estimate 
the average number of phosphate residues on the  talin molecules, 
BSC-1 cells were labeled for 16 h at  37 "C with either [32P]orth~- 
phosphate (carrier-free, Du Pont-New England Nuclear) or [36S] 
methionine (1331 Ci/mmol, Amersham) at 1 mCi/ml or 100 pCi/ml, 
respectively, in DMEM containing 10% fetal calf serum. Talin was 
immunoprecipitated from cells that had been treated with either TPA 
or Me2S0 for 20 min at  the  end of the labeling period. The number 
of moles of phosphate  in the  talin was determined by scintillation 
counting of the excised talin bands following electrophoresis. The 
number of moles of talin that were immunoprecipitated was deter- 
mined from the level of [35S]methionine incorporation assuming that 
each molecule of talin contains 45 methionine residues (Molony et 
al., 1987). The actual quantity of label in the media was determined 
by scintillation  counting and  the specific activity calculated from the 
previously determined  concentration of phosphate (0.9 mM in DMEM 
and 1.5 mM in  fetal calf serum) and methionine (0.2 mM in  DMEM 
and 0.03 mM in fetal calf serum). 
Two-dimensional Peptide Analysis-Immunoprecipitated talin 
from control or  TPA-treated 32P-labeled cells were incubated over- 
night at 37 "C with 100 pg/ml L-1-tosylamido-2-phenylethyl chloro- 
methyl ketone-treated  trypsin (Sigma) in 50 mM ammonium bicar- 
bonate,  pH 7.6. The  supernatants containing  tryptic  peptides were 
lyophilized and washed twice with distilled water. The final pellets 
were suspended in 10 pl of water. 5 pl of each sample was spotted 
onto  a thin layer cellulose plate. Peptide  separation was by electro- 
phoresis for 25 min at  1 kV in 1% ammonium carbonate buffer at  pH 
8.9 in the first dimension and by ascending chromatography in  n- 
butyl alcohol/pyridine/acetic acid/water (75:50:15:60) for 6 h. The 
plates were exposed to XAR-5 film (Kodak) for 3 weeks with an 
intensifying screen at  -70 "C. 
Phsphamino Acid Analy~is-~~P-Labeled  talin immunoprecipi- 
tated from TPA-treated BSC-1 cells electrophoresed on SDS gels and 
transferred to Imobilon (Millipore) membranes (Kamps and Sefton, 
1989) was subjected to phosphoamino acid analysis by hydrolysis in 
5.7 N HC1 for 60 min at 110 "C followed by electrophoresis and 
chromatography as described (Hunter  and Sefton, 1980). 
RESULTS 
Immunofluorescence-BSC-1 cells spread on glass cover- 
slips for 24-48 h in the presence of serum exhibited a network 
of short fine actin stress fibers (Fig. 1, b and d)  which 
terminated at focal adhesions as characterized by the presence 
of both  talin (Fig. la) and vinculin (Fig. IC). Following treat- 
ment of these cells with the tumor  promoter  TPA, an activator 
of protein kinase C, the majority of the  actin  stress fibers had 
disassembled by 20 min (Fig. 1, f and h). This was accom- 
panied by a  concurrent loss of vinculin (as described previ- 
ously  by Schliwa et al., 1984) (Fig. lg) and  talin (Fig. le) from 
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FIG. 1. Effects of tumor  promoter  (TPA) (a-h) or the  syn- 
thetic cAMP analogue dibutyryl-CAMP and methylisoxan- 
thine (Bt2cAMP/MIX) (i, j )  on the focal  adhesion  and stress 
fiber distribution in BSC-1 cells. Cells were treated with the 
respective drug for 20 min prior to fixation, permeabilization, and 
double labeling with talin or vinculin antisera  and rhodamine  phal- 
loidin to visualize the F-actin. In control cells talin (a )  and vinculin 
(c) are localized to focal adhesions into which stress fibers are inserted 
(b, d).  TPA treatment (100 ng/ml for 20 min) causes the loss of the 
majority of talin ( e )  and vinculin (g) staining from adhesions and  the 
disruption of accompanying stress fibers (f, h). Note that all  remain- 
ing stress fibers still have talin  and vinculin associated with their 
ends. Treatment of BSC-1 cells with BtZcAMP/MIX (2 mM for 20 
min) did not alter the normal talin (i) or F-actin 0 ' )  distribution. Bar 
= 20 pm. 
focal adhesions. However, both  talin  and vinculin were always 
observed at  the ends of any remaining stress fibers at  all time 
intervals (Fig. 1, e and g). We did not  detect  a preferential 
depletion of vinculin staining over that of talin  during the 
disruption of focal adhesions and  stress fibers. 
BSC-1 cells  were also treated with a mixture of 2 mM Btz- 
cAMP and 2 mM MIX,  both of which pass freely into cells, 
to activate the CAMP-dependent protein kinase (A kinase). 
This did not, however, alter the cell's normal cytoskeletal 
morphology  (Fig. 1, i and j )  confirming previous observations 
(Schliwa et al., 1984). 
In  sharp  contrast o these results, the stress fibers and focal 
adhesions of REF 52 cells  were readily disrupted by incubation 
in Bt2-cAMP/MIX as observed by Lamb et al. (1988). These 
cells normally have prominent  stress fibers (Fig. 2, b and d )  
which terminate  in extensive talin-  and vinculin-containing 
focal adhesions (Fig. 2, a and c) .  During incubation with the 
Bt2cAMP/MIX both the  stress fibers and  the focal adhesions 
FIG. 2. Effect of dibutyryl-CAMP (Bt2cAMP) (a-h) o r  the 
tumor  promoter  (TPA) (i, j )  on the distribution of talin, vin- 
culin,  and  F-actin  in  REF 52 cells.  In control cells, talin (a)  and 
vinculin (c) are concentrated in large focal adhesions into which 
stress fibers terminate (b, d).  Following treatment with BtzcAMP for 
20 min most of the  talin ( e )  and vinculin (g) is lost from the focal 
adhesions along with the majority of the  F-actin  stress fibers (f, h). 
All remaining stress fibers have vinculin and talin still present a t  
their  ends albeit  in reduced amounts. Treatment of REF 52 cells with 
TPA (100 ng/ml for 20 min) did not  alter  the normal talin (i) or F- 
actin 0 ' )  distribution. Bar = 20 pm. 
became progressively thinner with many of them being dis- 
rupted completely (Fig. 2, e-h). At no  time was talin  staining 
observed in the absence of vinculin or vice versa (data  not 
shown) and, as was the case with BSC-1 cells treated with 
TPA,  any  stress fibers remaining had  both  talin and vinculin 
associated with their ends (Fig. 2, e-h). Unlike BSC-1 cells, 
the  REF 52 cells demonstrated no change of stress fiber or 
focal adhesion organization following exposure to  TPA (Fig. 
2, i and j ) .  
P'SJMet Immunoprecipitation-To determine if limited 
proteolysis of talin or vinculin might play a role in the 
disruption of focal adhesions, in BSC-1 cells treated with 
TPA  or in REF 52 cells treated with B&cAMP/MIX, cells 
were metabolically labeled with [3'S]methionine. Following 
treatment with the appropriate drug to disrupt the cytoskel- 
eton,  talin  and vinculin were immunoprecipitated from these 
cells. Although a small amount of the 200-kDa proteolytic 
fragment of talin was observed in the material immunoprecip- 
itated from the drug-treated cells (Fig. 3, lanes 3 and 9), an 
equal quantity of both  intact  talin  and  the proteolytic frag- 
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FIG. 3. Disruption of focal adhesion and stress fiber integ- 
rity in BSC-1 cells by  TPA  and REF 52 cells by  Bt2cAMP/ 
MIX is not due to limited proteolysis of talin or vinculin. 
Following metabolic labeling with [35S]methionine for 2 h cells were 
treated with TPA or BtzcAMP for 20 min. Talin  and vinculin were 
subsequently immunoprecipitated and compared to the talin and 
vinculin recovered from control cells. Lune 1, '*'I markers  (kilodaltons 
X lanes 2-7, BSC-1 cells; lune 2, talin from control cells; lane 
3,  talin from TPA-treated cells; lune 4 ,  vinculin from control cells; 
lane 5, vinculin from TPA-treated cells; lunes 6 and 7, supernatants 
from control and  TPA-treated cells respectively; lanes 8-13, REF 52 
cells; lane 8, talin from control cells; lune 9, talin from BtZcAMP/ 
MIX-treated cells; lune 10, vinculin from control cells; lane 11, 
vinculin from BtzcAMP/MIX-treated cells; lanes 12  and 13, super- 
natants from control and BtzcAMP/MIX-treated cells, respectively. 
Note there is no change in the amount of talin or vinculin nor any 
increase in proteolytic fragments following either  drug treatment. 
8). Similarly, the amount of vinculin immunoprecipitated 
from the control and  drug-treated cells was the same in  all 
cases (Fig. 3, lanes 4 and  5  and 10 and 11). Similar analysis 
of [35S]methionine-labeled BSC-1 or REF 52 cells treated 
with TPA or Bt2cAMP/MIX, respectively, revealed no de- 
tectable changes in the  total protein profile (Fig. 3, lanes 6 
and 7, BSC-1; lanes 12 and 13, REF 52). These  data provide 
evidence that neither talin nor vinculin is proteolytically 
cleaved prior to their removal from focal adhesions under 
these experimental conditions. 
Phosphorylation-Since both TPA  and Bt2cAMP have the 
capacity to activate specific kinases (protein kinase C and 
CAMP-dependent kinase, respectively) the potential role of 
talin and/or vinculin phosphorylation in the disruption of 
focal adhesions was investigated following treatment of cells 
with these drugs. 
Immunoprecipitation of talin from BSC-1 cells prelabeled 
with inorganic 32P (see "Materials and Methods") and subse- 
quently treated with TPA for various lengths of time revealed 
a steady increase in the level of talin phosphorylation over a 
20-min period (Fig.  4, lanes 2-7), a  time course which paral- 
leled  focal adhesion disruption, as observed by immunofluo- 
rescence. Control cells treated with Me2S0 alone demon- 
strated basal levels of talin phosphorylation at all  time  points 
(Fig. 4, lanes 2, 4,  and 6), indicating that  the increase in  talin 
phosphorylation observed in the presence of TPA (lanes 3, 5, 
and 7) was not an artifact attributable to the presence of 
Me2S0. It should be noted that 4a-phorbol, an analogue of 
TPA which does not activate protein kinase C, caused no 
increase in  talin phosphorylation above the  Me2S0 control 
levels (data  not shown). Examination of the  total population 
of phosphorylated cellular proteins of cells incubated with 
TPA for 20 min (Fig. 4, lane 9) and control cells  (Fig. 4, lane 
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FIG. 4. Talin exhibits enhanced levels of phosphorylation 
in BSC-1 cells treated with TPA  but not with Bt2cAMP/MIX. 
BSC-1 cells prelabeled for 2 h  in  32P-containing medium were treated 
with TPA for 2, 5, and 20 min. Talin was subsequently immunopre- 
cipitated from these cells and compared with the talin recovered from 
control cells treated with MezSO alone for the same time periods. 
Lune I ,  lZ5I markers; lanes 2, 4 ,  and 6, talin from control (MezSO- 
treated cells; lanes 3, 5, and 7, talin from cells treated with TPA for 
2, 5, and 20 min, respectively. There was a steady increase in the 
level of talin phosphorylation with time in the TPA-treated cells 
while the control level of talin remained constant a t  all time points. 
Lanes 8 and 9, supernatants from control and TPA-treated cells, 
respectively; lanes IO and 11, control and Bt2cAMP-treated  BSC-1 
cells demonstrating that  this drug has no effect on the level of talin 
phosphorylation. 
8) revealed similar levels of protein phosphorylation, indicat- 
ing that  the  TPA did not cause a general increase in phos- 
phorylation levels. Similar analysis of talin immunoprecipi- 
tated from BSC-1 cells treated with Bt2cAMP/MIX (a case 
in which  focal adhesion and  stress fiber disruption was not 
observed) demonstrated that  the level of talin phosphoryla- 
tion remained constant  after  this  treatment (Fig.  4, lanes 10 
and 11). 
While BtzcAMP caused a  disruption of stress fibers and  the 
loss of talin  and vinculin from focal adhesions in REF 52 
cells, an increase in  talin phosphorylation in  these cells  was 
not observed. On the contrary, a small but reproducible de- 
crease in  the level of talin phosphorylation was detected (Fig. 
5, lane 5) .  This effect was specific for the Bt2cAMP/MIX 
since treatment of the  REF 52 cells with TPA (which does 
not  disrupt  their cytoskeletal organization) did not  alter the 
level of talin phosphorylation (Fig. 5, lanes 10 and 11). 
Analysis of the vinculin immunoprecipitated from BSC-1 
cells treated with TPA (Fig. 6, lane 3) or REF 52  cells treated 
with Bt2cAMP/MIX (Fig. 6, lane 5 )  revealed very low levels 
of phosphorylation similar to those found in  untreated cells 
(Fig. 6, lanes 2  and 4). Similarly, no change in phosphorylation 
was observed in the vinculin immunoprecipitated from BSC- 
1 cells treated with Bt2cAMP/MIX or REF 52  cells treated 
with TPA  (data not shown). 
Phosphopeptide Analysis and  Extent of Talin Phosphoryla- 
tion-The increase in  talin phosphorylation following TPA 
treatment was determined by scanning densitometry of au- 
toradiographs of immunoprecipitates to be approximately 3- 
fold (data  not shown). The  extent of phosphorylation of talin 
was measured by scintillation counting of talin immunopre- 
cipitated from BSC-1 cells labeled with [32P]orthophosphate 
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FIG. 5. Bt2cAMP/MIX treatment of REF 52 cells causes a 
small decrease in the level of talin phosphorylation while TPA 
has no effect. Lane 1, ''1 markers; lanes 2 and 4 ,  talin immunopre- 
cipitated from control cells a t  5 and 20 min; lanes 3 and 5, talin 
immunoprecipitated from BtzcAMP/MIX-treated cells also at  5 and 
20 min showing a small decrease in phosphorylation after 20 min of 
treatment in Bt2cAMP/MIX lunes 6-9, supernatants corresponding 
to lunes 2-5; lunes 10 and 21, talin immunoprecipitated from REF 52 
cells treated with TPA showing no change in phosphorylation levels 
after treatment with this drug. 
1 2 3  4 5  
FIG. 6. The levels of vinculin phosphorylation during focal 
adhesion disruption in BSC-1 cells treated with TPA and REF 
52 cells treated  with Bt2cAMP/MIX are low and unaffected 
by drug treatment. Lune 1, lz5I markers; lanes 2 and 3, vinculin 
immunoprecipitated from 32P-labeled BSC-1 cells, control, and TPA- 
treated cells, respectively; lunes 4 and 5,  vinculin immunoprecipitated 
from 32P-labeled REF 52 cells, control, and Bt2cAMP/MIX-treated 
cells, respectively. 
was estimated by scintillation counting of talin immunopre- 
cipitated from  cells labeled with [35S]methionine. Talin from 
BSC-1 cells treated with TPA contained 0.15 mol of phos- 
phate/mol of talin; control cells treated with Me2S0 alone 
contained 0.06 mol of phosphate/mol of talin. 
To determine if this increase was due to phosphorylation 
of a limited number of potential phosphorylation sites on the 
molecule, two-dimensional phosphopeptide maps of talin were 
generated. For these experiments, immunoprecipitated talin 
from both control and drug-treated cells  was  digested with 
trypsin. Two-dimensional peptide maps of the samples (Fig. 
7) revealed a limited number of phosphopeptides in both cases. 
FIG. 7. Phosphopeptide analysis of talin from control and 
TPA-treated BSC- 1 cells. Following drug treatment 32P-labeled 
talin was immunoprecipitated from lysed cells and digested with 
trypsin. The peptides were subjected to electrophoresis (left to right) 
followed  by chromatography (bottom to top) on thin layer chromatog- 
raphy plates. * denotes the origin. 
While four phosphopeptides exhibited approximately the 
same intensity (spots 4, 7, 10, and 11) and one clearly de- 
creased (spot 5), there was a major increase in 4 phosphopep- 
tides (spots 1-3 and 16) and 7 others showed minor increases 
(spots 6, 8, 9, 12-15) following treatment of the cells with 
TPA. Thus, it appears that the overall increase in talin 
phosphorylation we have observed is the result of increases 
in the phosphorylation levels of a selective subset of sites on 
the molecule. Phosphoamino acid analysis revealed that phos- 
phorylation was restricted to serine residues (data  not shown). 
DISCUSSION 
In  an  attempt  to understand  the mechanism which controls 
the integrity of focal adhesions and associated stress fibers 
within spread cells we have addressed in this paper two 
potentially relevant concepts, that of limited proteolytic cleav- 
age and  that of phosphorylation of two  major  focal adhesion 
components: talin and vinculin. Our data (summarized in 
Table I) suggest that  the loss of talin  and vinculin from  focal 
adhesions, which parallels stress fiber disruption in two  cell 
types following specific drug treatments, does not involve 
proteolytic cleavage of either protein. In  contrast,  the specific 
phosphorylation of talin by protein kinase C  in BSC-1 cells 
treated with TPA may  be an important factor in promoting 
the disassembly of focal adhesions and  stress fibers. However, 
an alternative mechanism seems likely in the case of focal 
adhesion disruption in  REF 52 cells treated with Bt2cAMP. 
Immunofluorescence-Both the tumor promoter TPA and 
a membrane-permeable analogue of CAMP (BbcAMP) are 
known to stimulate specific protein kinases. While they are 
both capable of inducing focal adhesion and  stress fiber dis- 
ruption their effect is cell type-specific, with TPA causing 
disruption in BSC-1 cells and Bt2cAMP in REF 52 cells. The 
reason for this is unclear. However, in both cases the sequence 
of events leading to  the loss of stress fibers and focal adhesions 
was similar. A gradual thinning of the stress fibers was  accom- 
panied by a decrease in the size of the talin and vinculin 
containing adhesions at  their ends. Although a sequential loss 
of focal adhesion components can be induced by certain 
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TABLE I 
Summary of drug  treatment  effects  on stress fibers and focal adhesions 
TPA db-CAMP 
BSC-1 REF 52 BSC-1 REF 52 
Focal adhesion and stress fiber disruption Yes No No Yes 
Talin phosphorylation Increase No change No change Decrease 
Vinculin phosphorylation No change No change No change No change 
Cleavage of talin or vinculin None None None None 
growth factors, such as platelet-derived growth factor (Her- 
man and Pledger, 1985), this seems to represent an excep- 
tional case. Our observations suggest that focal adhesion 
disassembly (stimulated via  specific kinase activation)  results 
from the simultaneous loss of talin  and vinculin. This loss 
occurs gradually following kinase activation and probably 
commences at  the periphery of the focal adhesion and  pro- 
gresses toward the center. 
Phosphorylation-The increase in talin phosphorylation 
that accompanied the disruption of stress fibers and focal 
adhesions in BSC-1 cells following TPA treatment was pos- 
sibly catalyzed directly by protein kinase C. TPA is known to 
activate this enzyme (Nishizuka, 1984), and talin has been 
shown to be a good substrate for protein kinase C in vitro 
(Beckerle et al., 1985; Litchfield and Ball, 1986). The absence 
of tyrosine phosphorylation on talin  supports  a direct phos- 
phorylation of talin by protein kinase C rather than via a 
tyrosine kinase, as was observed in the phosphorylation of 
talin or vinculin in transformed cells (Sefton et al., 1981; 
Pasquale et al., 1986;  DeClue and Martin, 1987). 
The basal level of talin phosphorylation we have observed 
is similar to  that reported by DeClue and  Martin (1987) for 
talin from uninfected and Rous sarcoma virus-transformed 
chicken embryo fibroblast cells (0.07  mol of phosphate/mol 
of talin). Our results concerning the stoichiometry of talin 
phosphorylation in  BSC-1 cells suggest that approximately 1 
in  7  talin molecules  (0.15 mol of phosphate/mol of talin) is 
phosphorylated following TPA  treatment while about 1 in 16 
(0.06 mol  of phosphate/mol of talin) is phosphorylated in the 
absence of TPA. The elevated talin phosphorylation occurs 
on several peptides following treatment of cells with TPA, 
indicating an even lower stoichiometry for talin molecules 
phosphorylated at a  particular site. One possible explanation 
for the low stoichiometry is that  the phosphorylation stimu- 
lated by TPA treatment is confined to talin within a specific 
compartment, the focal adhesion, and  that  this  is obscured by 
a large pool of soluble talin  that is not phosphorylated. Un- 
doubtedly, a pool of soluble talin exists, hut our attempts  to 
separate talin within the focal adhesions from that in the 
soluble pool have not been successful, due to the rapid disso- 
ciation of talin from focal adhesions in permeabilized cells 
and the loss of talin from these structures following TPA 
treatment. A second possible explanation for the low stoichi- 
ometry is if the phosphorylation occurs within focal adhesions 
resulting in the dissociation of talin from these  structures  and 
is followed by rapid dephosphorylation within the soluble 
pool. Since the disassembly of focal adhesions occurs over a 
20-min time course or more and we do not know the  rate of 
turnover of phosphates on talin,  this would  seem quite pos- 
sible. Site-directed mutagenesis of cDNA clones of talin may 
enable the specific sites of phosphorylation responsible for 
disruption to be identified. 
Whereas in BSC-1 cells TPA treatment led to disassembly 
of focal adhesions and a parallel increase in talin phosphory- 
lation, with REF 52 cells following TPA treatment  there was 
no significant disruption of focal adhesions and no increase 
in talin phosphorylation. This correlation of increased talin 
phosphorylation with focal adhesion disruption in response 
to TPA supports the hypothesis that  the phosphorylation of 
talin by protein kinase C may contribute to  the disruption of 
these  structures. 
In previous studies, investigators have concentrated on the 
possible role of vinculin phosphorylation in the regulation of 
cytoskeletal organization (Sefton et al., 1981; Werth and 
Pastan, 1984). The very low levels of vinculin phosphorylation 
observed in  our studies, compared with that of talin, suggest 
that  it is less likely to play a major role in regulating stress 
fiber and focal contact organization in the cell types employed 
in  this  study. 
The disruption of the focal adhesions in REF 52 cells 
following treatment with Bt2cAMP/MIX  is accompanied not 
by an increase in talin phosphorylation but  rather by a  de- 
crease. Although dephosphorylation could be important in 
affecting the interactions of talin with other  proteins, the low 
level of dephosphorylation leads us to suspect that an alter- 
native mechanism is responsible for focal adhesion disassem- 
bly in response to elevated CAMP. Previous work with REF 
52 cells demonstrated an increased phosphorylation of the 
myosin light chain kinase with an accompanying dephospho- 
rylation of the myosin light chain when the cells were treated 
with BtzcAMP or microinjected with the catalytic  subunit of 
the CAMP-dependent protein kinase (Lamb et al., 1988). 
Myosin light chain dephosphorylation would  be expected to 
diminish the force generating interaction between myosin and 
actin  and consequently result in less tension  in  stress fibers. 
Since tension may contribute to their development and size 
(Burridge, 1981), the decrease in  stress fiber tension may  be 
the primary cause of their  disruption in response to Bt2cAMP, 
with the loss of talin and vinculin from focal adhesions 
occurring secondarily. 
Proteolytic Cleauage-Selective limited proteolytic cleavage 
of focal adhesion components has been suggested as one way 
in which the linkage of actin  stress fibers with the plasma 
membrane could be disrupted (Beckerle et al., 1987). However, 
examination of immunoprecipitated talin  and vinculin from 
BSC-1 cells treated with TPA  or  REF 52 cells treated with 
BtzcAMP revealed no change in the level of proteolytic frag- 
ments of either  protein nor a decrease in the amount of the 
intact proteins. This argues against proteolysis of talin or 
vinculin being a mechanism for disassembly of focal adhesions 
or stress fibers and continues to focus attention on other 
secondary modifications such  as phosphorylation as  a way to 
regulate the interaction of the various focal adhesion proteins. 
Future  studies should be directed toward ascertaining if the 
phosphorylation of talin by protein kinase C  can be demon- 
strated to affect its interaction with vinculin or  integrin in 
vitro. 
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